Sphere Corp. (347700.KQ)
Seoul, KR
Sphere Corp. is a provider of advanced digital healthcare technology and holistic life care products and services. A core offering is LifeRecord, a proprietary personal health record platform designed to centralize and manage various health data points, including medical histories, genomic information, and user-generated health metrics. The company also offers a suite of digital healthcare services directly to consumers, which includes virtual treatment options, medication oversight, and general health and wellness management. Furthermore, Sphere Corp. facilitates patient communities, leveraging digital health enablement through solutions like digital therapeutics and artificial intelligence-powered software medical devices. Its product portfolio extends to manufacturing consumer medical devices for home use, professional medical equipment for healthcare settings, and a selection of other consumer goods. Established in Seoul, South Korea, in 2012, the company operated as LifeSemantics Corp. until its rebranding to Sphere Corp. in April 2025.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.94% | +0.36% | -14.23% | +55.15% | +412.14% | +121.06% | +342.35% | +799.79% | +266.96% | +141.14% | +141.14% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Medical - Healthcare Information Services: +14.2%+12.0% Q4'25: +1,081.9% (vs Q4'24)
-
EPS growth Medical - Healthcare Information Services: +43.1%-145.1%
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%-12.5% Q4'25: +19.8% (vs Q4'24)
-
EBIT margin Medical - Healthcare Information Services: +8.8%+9.0% ★ Q4'25: -65.5% (vs Q4'24)
-
ROIC Medical - Healthcare Information Services: +5.2%+11.2% ★ Q4'25: -111.2% (vs Q4'24)
-
Share dilution Medical - Healthcare Information Services: -0.1%+121.0%
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×1.38× Q4'25: -0.14× (vs Q4'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-04-30 | C | 2/5 | 1/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Byung Chul Choi | VP, CFO & Inside director | — | — |
| Kwang Soo Choi | Chairman of the Board of Directors & CEO | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 347700.KQ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
